2037DATE: 20 Feb., 2021
Dear Colleagues,
Enclosed are 57 PhD research projects offered by the academic staff in the College of Medicine, Nursing and Health Sciences (CMNHS) at the National University of Ireland (NUI) Galway, for 2021 recruitment of students funded by China Scholarship Council (CSC).
China Scholarship Council will be open for application on 10 March 2021, and students are required to submit a project application online, together with supporting documents, before the deadline of 31 March 2021.
Students are advised to visit the websites of potential supervisors, and contact them by email, and discuss with supervisors before drafting your CSC project. The email addresses and websites of the PhD supervisors can be found on the right column of the table below.
CMNHS supervisors will have access to research plan templates and letters.
Students are also welcome to contact me in my function as CMNHS CSC co-ordinator (Email: Sanbing.shen@nuigalway.ie; WeChat: sanbingshen) at NUI Galway for information, but I would urge that primarily each student makes contact with a supervisor from the list below, directly.
We are grateful if you, as our partner University, can help to advertise and recruit PhD students, who may be interested in applying the 2021 CSC funding scheme for doing a PhD at NUI Galway. We also encourage joint supervision and collaboration with PIs at your Institution.
Kind regards,
________________
Sanbing Shen, PhD
Professor of Fundamental Stem Cell Biology,
Regenerative Medicine Institute,
BMS-1021, Biomedical Science Building
Dangan, NUI Galway, Ireland. H91 TK33
Tel: +353-91-494261, 0872179387.
https://www.nuigalway.ie/our-research/people/sanbingshen/
Email: sanbing.shen@nuigalway.ie.
WeChat: sanbingshen
Project Number | Principal Investigator | Keyword 1 | Keyword 2 | Project Title | Contact (Email and Link to Research Profile) |
|
|
|
|
|
|
1 | Prof Tim O'Brien | Stem Cells | Diabetes | Therapeutic use of MSCs in the treatment of diabetic complications | timothy.obrien@nuigalway.ie; https://www.nuigalway.ie/our-research/people/timothyobrien/ |
2 | Prof Matt Griffin | Stem Cells | Diabetes | Human intermediate monocyte abnormalities in diabetic kidney disease. | |
3 | Prof Matt Griffin | Stem Cells | Diabetes | Regulatory T cell therapeutic effects in diabetic kidney disease. | |
4 | Prof Matt Griffin | Stem Cells | Diabetes | Mechanisms of mesenchymal stromal cell promotion of regulatory T cell expansion. | |
5 | Dr Karl McCullagh | Skeletal Muscle | Therapy | Vascular plasticity and target for therapy in Duchenne muscular dystrophy. | Karl.mccullagh@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/karlmccullagh/ |
6 | Dr Karl McCullagh | Skeletal Muscle | Therapy | The skeletal muscle-vascular axis in Duchenne Muscular Dystrophy | Karl.mccullagh@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/karlmccullagh/ |
7 | Dr Brian McDonagh | Physiology | Disease | Exercise mediated redox regulation of microRNA biogenesis | brian.mcdonagh@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/brianmcdonagh/ |
8 | Dr Amir Shafat | Physiology | Disease | Gastrointestinal motility in health and disease | Amir.shafat@nuigalway.ie; http://www.nuigalway.ie/ourresearch/people/amirshafat/ |
9 | Dr Amir Shafat; Dr Karl McCullagh; Dr Brian McDonagh | Physiology | Disease | The role of lactate in metabolic physiology and diabetes | Amir.shafat@nuigalway.ie; karl.mccullagh@nuigalway.ie; brian.mcdonagh@nuigalway.ie |
10 | Prof Terence Prendiville, Prof Sanbing Shen | Stem Cells | Cardiology | Phenotypic characterisation of human iPSCs for LQTS heart diseases | |
11 | Prof Sanbing Shen | Stem Cells | Autism | Phenotypic characterisation of human induced pluripotent stem cells (iPSCs) for Autism. | Sanbing.shen@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/sanbingshen/; WeChat: sanbingshen |
12 | Prof Sanbing Shen | Stem Cells | Chinese Medicine | Genome editing and construction of report iPSC lines for of screening of Chinese medicine | Sanbing.shen@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/sanbingshen/; WeChat: sanbingshen |
13 | Dr Ronan MT Fleming | Stem Cells | Parkinsons | Microfluidic cell culture of stem cell-derived neuronal models of Parkinson's disease | ronan.mt.fleming@nuigalway.ie; http://www.nuigalway.ie/webtest/r onan.html; +353-87-341-3072 |
14 | Dr Ananya Gupta | Exercise | Cancer | Pre-operative exercise interventions for lung cancer patients | ananya.gupta@nuigalway.ie; http://www.nuigalway.ie/ourresearch/people/ananyagupta/; http://spark.adobe.com/page/Kqp0lxsRjKr63/ |
15 | Dr Ananya Gupta | Chemotherapy | Cancer | Management and prevention of chemotherapy induced toxicity in Cancer treatment | ananya.gupta@nuigalway.ie; http://www.nuigalway.ie/ourresearch/people/ananyagupta/; http://spark.adobe.com/page/Kqp0lxsRjKr63/ |
16 | Dr Ananya Gupta | Chemotherapy | Cancer | Exercise as Therapy and its Application in Cancer rehabilitation | ananya.gupta@nuigalway.ie; http://www.nuigalway.ie/ourresearch/people/ananyagupta/; http://spark.adobe.com/page/Kqp0lxsRjKr63/ |
17 | Dr Sanjeev Gupta | Chemotherapy | Cancer | Targeting endocrine resistance in breast cancer by modulators of Unfolded Protein Response | Sanjeev.gupta@nuigalway.ie; http://www.nuigalway.ie/medicine-nursing-and-health-sciences/medicine/disciplines/pathology/research2/sanjeevgupta/ |
18 | Dr Sanjeev Gupta | non-coding RNAs | Cancer | Role of non-coding RNAs in regulation of cancer progression and cell death | Sanjeev.gupta@nuigalway.ie; http://www.nuigalway.ie/medicine-nursing-and-health-sciences/medicine/disciplines/pathology/research2/sanjeevgupta/ |
19 | Dr Sanjeev Gupta | Chemotherapy | Cancer | Molecular mechanisms of resistance to chemotherapy treatment in breast cancer | https://scholar.google.com/citations?user=ESImKpcAAAAJ&hl=en |
20 | Dr Leo Quinlan | Physiology | Disease | The skeletal muscle secretome in health and disease. | leo.quinlan@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/leoquinlan |
21 | Dr Leo Quinlan | Physiology | Disease | Targeting the chrondrocyte channelome in osteoarthritis. | leo.quinlan@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/leoquinlan |
22 | Dr Leo Quinlan | Physiology | Disease | Targeting barrier function in bladder disease | leo.quinlan@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/leoquinlan |
23 | Dr Leo Quinlan | Physiology | Disease | IPS cell and biomaterials for the treatment of neurodegenerative diseases specifically Parkinson’s and Alzheimers disease. | leo.quinlan@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/leoquinlan |
24 | Prof Ines Thiele | Gut-Brain Axis |
| Elucidation of deranged metabolic pathways in cognitive decline and Alzheimer's disease using computational modeling of gut microbiome data. | ines.thiele@nuigalway.ie; https://www.nuigalway.ie/medicinenursing-and-health-sciences/staffprofiles/inesthiele/ |
25 | Prof Ines Thiele | Gut-Brain Axis |
| Computational modeling of the gut-brain axis in neurodegeneration. | ines.thiele@nuigalway.ie; https://www.nuigalway.ie/medicinenursing-and-health-sciences/staffprofiles/inesthiele/ |
26 | Prof Ines Thiele | Gut-Brain Axis |
| Computational modeling of Chinese Medicine products | ines.thiele@nuigalway.ie; https://www.nuigalway.ie/medicinenursing-and-health-sciences/staffprofiles/inesthiele/ |
27 | Dr Sinéad Hynes | Neurology / Rehabilitation |
| Adapting and testing a cognitive rehabilitation programme for people with multiple sclerosis (primary progressive) | Sinead.hynes@nuigalway.ie; http://www.nuigalway.ie/ourresearch/people/health-sciences/sineadhynes/index.html |
28 | Dr Karen Doyle | Stroke |
| Understanding the clots that cause strokes: a compositional and proteomic analysis of acute ischaemic stroke blood clots. | Karen.doyle@nuigalway.ie; Tel: https://www.nuigalway.ie/ourresearch/people/medicine/karendoy le/ |
29 | Prof Michael O'Dwyer | Cancer |
| Development of natural killer cells from human induced pluripotent stem cells. | michael.odwyer@nuigalway.ie; http://www.nuigalway.ie/ourresearch/people/medicine/michaelo dwyer/ |
30 | Prof Michael Kerin | Cancer |
| Characterisation of oncological properties of traditional Chinese medicine derived products in vitro. | michael.kerin@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/medicine/michaelk erin/ |
31 | Prof Michael Kerin | Cancer |
| Mode of action of impactful Chinese anticancer therapy. | michael.kerin@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/medicine/michaelk erin/ |
32 | Dr Katarzyna Goljanek-Whysall | MicroRNA | Muscle | The role of microRNAs in muscle wasting | kasia.whysall@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/kasiawhysall/ |
33 | Dr Katarzyna Goljanek-Whysall | MicroRNA | Muscle | MicroRNAs for tissue rejuvenation through elimination of senescent cells | kasia.whysall@nuigalway.ie; https://www.nuigalway.ie/ourresearch/people/kasiawhysall/ |
34 | Prof Mary Murphy | Stem Cells | Osteoarthritis | Stem cells: basic mechanisms of action in disease/therapy using | mary.murphy@nuigalway.ie; https://www.nuigalway.ie/our-research/people/marymurphy/ |
35 | Prof Aoife Lowery | Cancer |
| Evaluation of Ablative Approaches to Breast Cancer Treatment - Microwave Ablation & Irreversible Electroporation | |
36 | Prof Aoife Lowery | Cancer | Regeneration | Adipose derived stem cells and hydrogels for novel tissue engineering approaches to breast reconstruction | aoife.lowery@nuigalway.ie, https://www.nuigalway.ie/our-research/people/medicine/aoifelowery/, http://www.nuigalway.ie/womeninmedicine/ |
37 | Prof John J Carey | Osteoporosis |
| The DXA-HIP Project (Dual-energy X-ray Absorptiometry - Health Informatics Prediction) Project | john.j.carey@nuigalway.ie , https://www.nuigalway.ie/our-research/people/medicine/johnjcarey/ |
38 | Prof John J Carey | Non-Communicable Diseases |
| The DXA-HIP Project (Dual-energy X-ray Absorptiometry - Health Informatics Prediction) Project | john.j.carey@nuigalway.ie , https://www.nuigalway.ie/our-research/people/medicine/johnjcarey/ |
39 | Dr Michael Conall Dennedy | Cancer | Imaging | Targetting abnormal steroidogenesis using nanotechnology. A novel approach to adrenal endocrinology. | |
40 | Prof Declan Devane | Methodology research |
| Improving efficiency in design, conduct and reporting of systematic reviews and other evidence syntheses | |
41 | Prof Declan Devane | Methodology research |
| Improving efficiency in design, conduct and reporting of randomised trials | |
42 | Prof Declan Devane | Informed public |
| Improving critical thinking to assess claims about the effects of treatments (Informed Health Choices) | |
43 | John W (BILL) McEvoy | Preventive Cardiology | Cardiovascular Health | A mechanistic randomized trial testing the effect of physical activity on vascular function and metrics of cardiovascular health | |
44 | Prof Declan Devane | Informed public |
| Evaluating the effects of interventions for misinformation and disinformation in cancer | |
45 | John W (BILL) McEvoy | Preventive Cardiology | Cardiovascular Health | Air Quality and Cardiovascular Health, deploying a unique attribute of the China-Galway Collaboration | |
46 | Dr Barry McDermott | Obstetrics - Postpartum Haemorrhage |
| Development of a novel low-cost, robust device for prevention and treatment of Post-Partum Haemorrhage in low-resource settings. | |
47 | Dr Sinéad Hynes | Neurology/Rehabilitation |
| Developing a vocational rehabilitation intervention for people with multiple sclerosis | |
48 | Dr Sinéad Hynes | Dementia |
| Developing an intervention to support people with dementia and family carers living in the community. | |
49 | Dr. Daniel O'Toole | Stem Cells | Respiratory Disease | The effects of the inflammatory injury microenvironment on in vivo MSC function. | |
50 | Dr. Daniel O'Toole | Stem Cells | Respiratory Disease | Modifying macrophage polarisation to reduce lung disease. | |
51 | Prof Antony Wheatley Dr Ananya Gupta | Physiology | Cancer | Characterisation of UPR regulated modulators of Tumor Angiogenesis | |
52 | Dr Michelle Roche | Neuroscience | Physiology | Neurobiological mechanisms underlying altered pain responding in autism | michelle.roche@nuigalway.ie; (https://www.nuigalway.ie/our-research/people/michelleroche/) |
53 | Dr Róisín Dwyer | Breast Cancer |
| Mesenchymal Stromal Cells (MSCs) for tumour-targeted treatment of advanced breast cancer | roisin.dwyer@nuigalway.ie; http://www.nuigalway.ie/our-research/people/medicine/roisindwyer/ |
54 | Dr Róisín Dwyer | Breast Cancer |
| Dynamic 3D in vitro tissue models to study extracellular vesicle (EV) exchange and mechanism of action in breast cancer/lymph node metastases | roisin.dwyer@nuigalway.ie http://www.nuigalway.ie/our-research/people/medicine/roisindwyer/ |
55 | Dr Róisín Dwyer | Breast Cancer |
| Impact of stromal-epitheilal interactions on lymph node metastasis in breast cancer | roisin.dwyer@nuigalway.ie http://www.nuigalway.ie/our-research/people/medicine/roisindwyer/ |
56 | Dr. Firas Awaja | Tissue Engineering | Bone | Load bearing adhesive for bone fractures | Firas.awaja@nuigalway.ie |
57 | Dr. Firas Awaja | Tissue Engineering | Bone | Graphene based materials for bone regeneration | |
| Dr. Firas Awaja | Tissue Engineering | Angiogenesis | Graphene based materials for angiogenesis | Firas.awaja@nuigalway.ie |
2021年国家留学基金资助出国留学人员选派简章
第一章 总则
第一条 深入贯彻落实习近平新时代中国特色社会主义思想，为全面建设社会主义现代化国家提供人才支撑，为构建人类命运共同体搭建中外人文交流平台，推动国家公派留学在新时代教育对外开放中发挥更大作用。
第二章 选派计划和主要项目
第二条 2021年计划选派各类国家公派出国留学人员27000名。
第三条 主要选派类别及留学期限
1. 高级研究学者：3–6个月。
2. 访问学者：3–12个月。
3. 博士后：6–24个月。
4. 赴国外攻读博士学位研究生：一般为36–48个月，具体以留学目的国及院校学制或外方出具的录取通知书或邀请信为准。
5. 联合培养博士生（在国内攻读博士学位期间赴国外从事研究）：6–24个月。
6. 赴国外攻读硕士学位研究生：一般为12–24个月,具体以留学目的国及院校学制或外方出具的录取通知书或邀请信为准。
7. 联合培养硕士生（在国内攻读硕士学位期间赴国外学习）：3–12个月。
8. 赴国外攻读学士学位本科生：一般为36–60个月，具体以相关项目规定为准。
9. 本科插班生（在国内攻读学士学位期间赴国外学习、毕业设计或实习等）：3–12个月。
第四条 主要项目
1. 国家公派高级研究学者、访问学者、博士后项目计划选派2700人。选派类别包括高级研究学者、访问学者和博士后。
2. 国家建设高水平大学公派研究生项目计划选派10500人，选派类别包括赴国外攻读博士学位研究生和联合培养博士生；博士生导师短期出国交流项目计划选派300人，选派类别为高级研究学者。
3. 高校合作项目（青年骨干教师出国研修项目）计划选派1650人，选派类别包括访问学者和博士后。
4. 地方和行业部门合作项目计划选派3320人，其中西部地区人才培养特别项目及地方合作项目1770人，选派类别包括高级研究学者、访问学者和博士后；与行业部门合作项目1550人。
5. 国际组织人才培养项目计划选派950人，其中国际组织实习项目750人，选派类别为实习生、访问专家等；国际组织后备人才培养项目200人，选派类别包括赴国外攻读硕士学位研究生和联合培养硕士生。
6. 国际区域问题研究及外语高层次人才培养项目和政府互换奖学金项目计划选派2230人，选派类别包括访问学者、博士后、赴国外攻读博士学位研究生、联合培养博士生、赴国外攻读硕士学位研究生、联合培养硕士生、赴国外攻读学士学位本科生和本科插班生。
7. 艺术类人才特别培养项目计划选派200人，选派类别包括访问学者、博士后、赴国外攻读博士学位研究生、联合培养博士生、赴国外攻读硕士学位研究生和联合培养硕士生。
8. 乡村振兴人才培养专项计划选派200人，选派类别包括访问学者、赴国外攻读硕士学位研究生和联合培养硕士生。
9. 国外合作项目计划选派4950人。国外合作项目是指与外方机构签署协议并由中外双方联合评审、联合资助的项目，如国家留学基金委剑桥奖学金、中法“蔡元培”交流合作项目、中德（CSC-DAAD）博士后奖学金项目、与瑞典皇家理工学院合作奖学金、创新型人才国际合作培养项目等。
第三章 资助内容
第五条 资助内容一般为一次往返国际旅费和资助期限内的奖学金。奖学金包括伙食费、住宿费、注册费、板凳费（bench fee）、交通费、电话费、书籍资料费、医疗保险费、交际费、一次性安置费、签证延长费、零用费、手续费和学术活动补助费等。对部分人员可提供学费资助。具体资助方式、资助标准等以录取文件为准。
第四章 申请条件
第六条 申请人基本条件
1. 拥护中国共产党的领导和中国特色社会主义制度，热爱祖国，具有服务国家、服务社会、服务人民的责任感和端正的世界观、人生观、价值观。
2. 具有良好专业基础和发展潜力，在工作、学习中表现突出，具有学成回国为国家建设服务的事业心和使命感。
3. 具有中华人民共和国国籍，不具有国外永久居留权。申请时年龄满18周岁。
4. 身体健康，心理健康。
5. 符合国家留学基金资助出国留学外语条件及留学国家、留学单位的语言要求。
6. 符合申请项目的其它具体要求。
第七条 暂不受理以下人员的申请
1. 已获得国外全额奖学金资助。
2. 已获得国家公派留学资格且在有效期内。
3. 已申报国家公派出国留学项目尚未公布录取结果。
4. 曾获得国家公派留学资格，未经国家留学基金委批准擅自放弃且时间在5年以内，或经国家留学基金委批准放弃且时间在2年以内（因疫情原因申请放弃公派留学资格或资格有效期内未能派出的除外）。
5. 曾享受国家留学基金资助出国留学、回国后服务尚不满两年。项目有特殊规定的，按相关规定执行。
第五章 选拔办法
第八条 遵循“公开、公平、公正”的原则，采取“个人申请，单位推荐，专家评审，择优录取”的方式进行选拔。
第九条 推选单位需对申请人的政治思想、师德师风/品行学风等严格把关，并在申请表主表单位推荐意见栏中对上述表现做出评价。
第十条 符合申请条件者，应按规定程序和办法申请。国家留学基金管理委员会根据相关项目要求，组织评审，确定录取结果。申请人可登录国家公派留学管理信息平台（http://apply.csc.edu.cn）查询录取结果，下载、打印录取材料。
第十一条 主要项目申请、录取时间
1. 国家公派高级研究学者、访问学者、博士后项目：4月10日–30日申请，6月下旬公布录取结果。
2. 国家建设高水平大学公派研究生项目：攻读博士学位研究生3月10日–31日申请，5月公布录取结果（部分中外合作协议/项目需与外方合作院校/机构确认录取结果，公布时间略晚）；联合培养博士研究生5月10日-31日申请，7月公布录取结果。
3. 青年骨干教师出国研修项目：9月10日–30日申请，11月公布录取结果。
4. 地方和行业部门合作项目：
①西部地区人才培养特别项目及地方合作项目（含已获批的地方创新子项目人员）：5月1日–15日申请，8月公布录取结果。
②与行业部门合作项目按照相应项目规定施行。
5. 国际组织人才培养项目：
①国际组织实习项目：单位或个人联系渠道全年随时申请，每月公布录取结果；国家留学基金委与有关国际组织合作项目每年均需国际组织提供岗位后发布，全年随时发布。
②国际组织后备人才培养项目：国内高校渠道，已获批项目的人员申报时间为5月10日-31日，6月公布录取结果；国家留学基金委合作渠道申请信息将在项目专栏中另行公布。
6. 国际区域问题研究及外语高层次人才培养项目：3月20日–30日申请，5月公布录取结果。
7. 政府互换奖学金根据相应规定施行。
8. 创新型人才国际合作培养项目：2020年11月28日前项目申请，2021年2月公布获批项目；2021年3月1日-10日第一批人选申请，4月公布录取结果；9月1日-10日第二批人选申请，10月公布录取结果。
9. 艺术类人才培养特别项目：3月10日–31日申请，5月公布录取结果。
10. 乡村振兴人才培养专项：2021年4月1日-10日组织往年获批项目试点实施单位人选申请，6月公布录取结果；2021年9月1日-10日项目申请，10月公布获批项目；2022年4月1日-10日人选申请，6月公布录取结果。
11. 国外合作项目根据相应项目规定施行。
第六章 派出与管理
第十二条 推选单位对本单位人员承担管理主体责任。
第十三条 被录取人员须在留学资格有效期内派出。未按期派出者，留学资格自动取消。
第十四条 对留学人员实行“签约派出，违约赔偿”的管理办法。派出前，留学人员须按要求签署《国家公派出国留学协议书》，协议书经国家留学基金委审核通过后生效；办理国家公派留学奖学金专用银行卡；办理护照、签证、《国际旅行健康证书》；通过教育部留学服务中心、教育部出国人员上海集训部、广州留学人员和高层次人才服务中心办理预定机票、《国家公派留学人员报到证明》等手续（具体请查阅《出国留学人员须知》）。
第十五条 留学人员自抵达留学所在国后10日内凭《国家留学基金资助出国留学资格证书》及相关材料向中国驻留学所在国使（领）馆办理报到手续，具体按照驻留学所在国使（领）馆要求办理。
第十六条 留学人员在国外留学期间，应遵守所在国法律法规、国家留学基金资助出国留学人员的有关规定及《国家公派出国留学协议书》的有关约定，自觉接受国内推选单位和驻外使（领）馆的指导和管理，定期向推选单位提交研修报告。
第十七条 留学人员学成后应按期回国履行回国服务义务，回国之日起3个月内须在国家公派留学管理信息平台登记回国信息。本科插班生无回国服务期要求。
第十八条 留学人员与获得资助有关的论文、研究项目或科研成果在成文、发表、公开时，应注明“本研究/成果/论文得到中国国家留学基金资助”。
电子营业执照